< Back to Article
Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients
Figure 6
Association between glucuronidation of belinostat and UGT1A1 substrates (A, B, and C).
A: Bilirubin-G; B: thyroxine-4-G/CPT-11; C: SN38-G/CPT11.
doi: https://doi.org/10.1371/journal.pone.0054522.g006